NEWS OF THE WEEK
			ARTERIAL OZONE Ozonated cholesterols are the calling cards of O3's role in cardiovascular disease.
			IN MEMORIAM: STANLEY C. ISRAEL ACS director-at-large dies suddenly at age 60.
			FLAME-RETARDANT PHASEOUT Great Lakes Chemical voluntarily halts production of two polybrominated diphenyl ethers.
			GENERIC DRUG DEAL Teva to buy Sicor for $3.4 billion, adding injectables to its generic drug slate.
			PROTEIN FOLDING Researchers show that a protein made from scratch can fold like a native.
			PLAGUE TRIAL Nobel Laureates object as trial of Texas Tech researcher Thomas C. Butler gets under way.
			CHEMICAL SAFETY Accident investigation board loses two members, but replacements are nominated.
			MOLECULAR THERMOMETERS Fluorescent polymer devices should be able to read nanospace temperatures.
			ARMORED SNAILS Indian Ocean sea snails cover their feet with scales that incorporate iron sulfides.

COVER STORY
			DRUG FRAUD FDA investigates growing numbers of counterfeit drug cases, as secondary wholesalers provide a ready outlet for fake, diverted, and adulterated drugs. Cover: Photodisc

BUSINESS
			BUSINESS CONCENTRATES
			PHARMACEUTICAL INGREDIENTS At CPhI in Frankfurt, opinions held that small-scale manufacturing capabilities and niche expertise could stimulate growth.
			NEW R&D CENTER IN NORTHERN IRELAND Chemical Synthesis Services opens state-of-the-art laboratories in Craigavon.
			E-BUSINESS

GOVERNMENT & POLICY
			GOVERNMENT CONCENTRATES
			DOE'S SCIENCE A panel report, reorganization, and 20-year spending plan could reshape Energy Department's science mission.
			HINDSIGHTS Professionally gathered and objectively evaluated intelligence is an essential component of national security.

SCIENCE/TECHNOLOGY
			SCIENCE/TECHNOLOGY CONCENTRATES
			LASSO PEPTIDE Three research groups independently report structure of a lariat-shaped antibacterial peptide.
			OPEN SESAME Middle Eastern coalition plans to open the region's first synchrotron in 2007.

BOOKS
			"THE PATHOLOGICAL PROTEIN" Informative story of prion diseases raises questions about how governments missed experts' warnings.

ACS COMMENT
			NETWORKING FOR ALL CHEMISTS

THE DEPARTMENTS
		EDITOR'S PAGE
		LETTERS
		ACS NEWS
		PEOPLE
		NEWSCRIPTS